Zobrazeno 1 - 10
of 28
pro vyhledávání: '"LouAnn Cable"'
Autor:
Hairui Su, Ming Jiang, Chamara Senevirathne, Srinivas Aluri, Tuo Zhang, Han Guo, Juliana Xavier-Ferrucio, Shuiling Jin, Ngoc-Tung Tran, Szu-Mam Liu, Chiao-Wang Sun, Yongxia Zhu, Qing Zhao, Yuling Chen, LouAnn Cable, Yudao Shen, Jing Liu, Cheng-Kui Qu, Xiaosi Han, Christopher A. Klug, Ravi Bhatia, Yabing Chen, Stephen D. Nimer, Y. George Zheng, Camelia Iancu-Rubin, Jian Jin, Haiteng Deng, Diane S. Krause, Jenny Xiang, Amit Verma, Minkui Luo, Xinyang Zhao
Publikováno v:
Cell Reports, Vol 36, Iss 4, Pp 109421- (2021)
Summary: Mitogen-activated protein kinases (MAPKs) are inactivated by dual-specificity phosphatases (DUSPs), the activities of which are tightly regulated during cell differentiation. Using knockdown screening and single-cell transcriptional analysis
Externí odkaz:
https://doaj.org/article/c390eca951f14661aa1b8d2ec69d2ff2
Autor:
Rami Komrokji, Hagop Kantarjian, Alan List, Zach Bohannan, Monica Cabrero Calvo, Mieke Ptaszynski, Grant Hogeland, Lara Maloney, Selena Rush, LouAnn Cable, Shannon L. Winski, Jeffrey Lancet, Elias Jabbour, Hanna J. Khoury, Guillermo Garcia-Manero
Figure S1. EPO and plasma chemokine expression following treatment with ARRY-614 at 1200 mg QD. Figure S2. Comparison of EPO in IWG2006 Responders and Non-Responders.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2749539b558aaeff86cdad94db594726
https://doi.org/10.1158/1078-0432.22461647.v1
https://doi.org/10.1158/1078-0432.22461647.v1
Autor:
Rami Komrokji, Hagop Kantarjian, Alan List, Zach Bohannan, Monica Cabrero Calvo, Mieke Ptaszynski, Grant Hogeland, Lara Maloney, Selena Rush, LouAnn Cable, Shannon L. Winski, Jeffrey Lancet, Elias Jabbour, Hanna J. Khoury, Guillermo Garcia-Manero
Purpose: Data suggest that activity of p38 MAPK and Tie2 kinases is dysregulated in myelodysplastic syndromes (MDS) and may be targets for novel therapies. A phase I study of ARRY-614, an oral dual inhibitor of p38 MAPK and Tie2, was conducted in pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b60d5f52fbd9e9d5a154f342f65d7d7a
https://doi.org/10.1158/1078-0432.c.6524846.v1
https://doi.org/10.1158/1078-0432.c.6524846.v1
Autor:
Rami Komrokji, Hagop Kantarjian, Alan List, Zach Bohannan, Monica Cabrero Calvo, Mieke Ptaszynski, Grant Hogeland, Lara Maloney, Selena Rush, LouAnn Cable, Shannon L. Winski, Jeffrey Lancet, Elias Jabbour, Hanna J. Khoury, Guillermo Garcia-Manero
Supplemental Table 2. Dose escalation PK parameters for ARRY-614
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98ae6d70f6b3f0940c1ec0aca3daa6cd
https://doi.org/10.1158/1078-0432.22461650
https://doi.org/10.1158/1078-0432.22461650
Autor:
Rami Komrokji, Hagop Kantarjian, Alan List, Zach Bohannan, Monica Cabrero Calvo, Mieke Ptaszynski, Grant Hogeland, Lara Maloney, Selena Rush, LouAnn Cable, Shannon L. Winski, Jeffrey Lancet, Elias Jabbour, Hanna J. Khoury, Guillermo Garcia-Manero
Supplemental Table 1. Treatment-emergent AEs (safety population)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::071bb0c0accd07d3d7702ce3c4eeb15c
https://doi.org/10.1158/1078-0432.22461653
https://doi.org/10.1158/1078-0432.22461653
Autor:
Edgar R. Wood, Lisa Shewchuk, Anne T. Truesdale, H. Luke Carter, Ermias Woldu, Kathleen T. Gallagher, Glenn Spehar, David Rusnak, Krystal Alligood, Louann Cable, Tona M. Gilmer
The goal of this study was to characterize the effects of non–small cell lung carcinoma (NSCLC)-associated mutations in epidermal growth factor receptor (EGFR/ErbB1) and HER2 (ErbB2) on interactions with the dual tyrosine kinase inhibitor lapatinib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4634a8f47176a77086f78bb49fe819c
https://doi.org/10.1158/0008-5472.c.6497225
https://doi.org/10.1158/0008-5472.c.6497225
Autor:
Edgar R. Wood, Lisa Shewchuk, Anne T. Truesdale, H. Luke Carter, Ermias Woldu, Kathleen T. Gallagher, Glenn Spehar, David Rusnak, Krystal Alligood, Louann Cable, Tona M. Gilmer
Supplementary Text, Tables 1-4 from Impact of Common Epidermal Growth Factor Receptor and HER2 Variants on Receptor Activity and Inhibition by Lapatinib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c918b4497cf8e3597ec4b6fda7c3806
https://doi.org/10.1158/0008-5472.22373843
https://doi.org/10.1158/0008-5472.22373843
Autor:
Anna Guarnieri, Karyn Bouhana, LouAnn Cable, Rob Rieger, Leyla Haygood, John Robinson, Shannon Winski
Publikováno v:
Cancer Research. 82:147-147
KIT is a well characterized oncogenic driver, mutated in up to 80% of gastro-intestinal stromal tumors (GIST). Front-line imatinib is effective in many patients but durable responses in the setting of imatinib failure are rarely achieved due to compl
Autor:
Anna Guarnieri, Mark Chicarelli, LouAnn Cable, Francis Sullivan, Howard Ball, Shannon Winski, John Robinson
Publikováno v:
Molecular Cancer Therapeutics. 20:P257-P257
KIT is a well characterized oncogenic driver of gastro-intestinal stromal tumors (GIST) and systemic mastocytosis (SM), and targeted therapeutics have offered valuable treatment options for these patients. Durable responses in imatinib-resistant GIST
Autor:
John A. Robinson, Francis J. Sullivan, Jessica Sachs, Howard Ball, Karyn Bouhana, Shannon L. Winski, LouAnn Cable, Mark Joseph Chicarelli, Anna Guarnieri
Publikováno v:
Blood. 138:4595-4595
The molecular pathogenesis of Systemic Mastocytosis (SM) is driven by mutations in the KIT gene, with 95% of patients having a mutation in exon 17, D816V, leading to constant proliferation of mast cells (Garcia-Montero et al, 2006; Jara-Acevedo et al